Skip to main content
Santhosh Sadashiv, MD, Hematology, Pittsburgh, PA

Santhosh Kukkadi Sadashiv MD

Hematologic Oncology


Associate Program Director Division of Hematology and Cellular Therapy

Join to view full profile
  • 4815 Liberty AveSte 322Pittsburgh, PA 15224

  • Phone+1 412-578-4484

  • Fax+1 412-578-3536

Dr. Sadashiv is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Allegheny Health Network Medical Education Consortium (WPH/AGH)
    Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2011 - 2014
  • UMass Chan - Baystate
    UMass Chan - BaystateFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
  • One Brooklyn Health System/Brookdale University Hospital and Medical Center
    One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
  • Siddhartha Medical College NTR
    Siddhartha Medical College NTRClass of 1998

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2003 - 2026
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.  
    Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014
  • Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.  
    Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014
  • Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.  
    Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014

Abstracts/Posters

  • Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65 Year-Old, 12-Years Analysis of National Cancer Database
    Santhosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Impact of Socioeconomic Factors on Timeliness of First Line Chemotherapy and Survival in Patients with Active Multiple Myeloma
    Santhosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • In-Hospital Complications and Outcomes of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65-Years Old in the United States: National Inpa...
    Santhosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • The Risk Factors of the Venous Thromboembolism in Hospitalized Patients with Hematologic Malignancies in the United States: National Inpatient Sample Analysis, 2011-2015 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • VTE Risk and Incidence in Hospitalized Patients with Blood Cancers
    VTE Risk and Incidence in Hospitalized Patients with Blood CancersOctober 25th, 2019
  • Doctors Making Progress in Treating Amyloidosis
    Doctors Making Progress in Treating AmyloidosisMarch 7th, 2019
  • Pittsburgh-Area Businessmen, Friends Diagnosed with Rare Blood Cancer 4 Months Apart
    Pittsburgh-Area Businessmen, Friends Diagnosed with Rare Blood Cancer 4 Months ApartJuly 12th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: